LPL Financial’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.57M | Buy |
134,469
+26,980
| +25% | +$314K | ﹤0.01% | 3324 |
|
|
2025
Q1 | $799K | Sell |
107,489
-10,127
| -9% | -$75.2K | ﹤0.01% | 3707 |
|
|
2024
Q4 | $705K | Sell |
117,616
-8,470
| -7% | -$50.8K | ﹤0.01% | 3746 |
|
|
2024
Q3 | $646K | Sell |
126,086
-10,193
| -7% | -$52.2K | ﹤0.01% | 3726 |
|
|
2024
Q2 | $493K | Buy |
136,279
+28,839
| +27% | +$104K | ﹤0.01% | 3826 |
|
|
2024
Q1 | $345K | Buy |
107,440
+6,211
| +6% | +$19.9K | ﹤0.01% | 4031 |
|
|
2023
Q4 | $496K | Buy |
101,229
+19,761
| +24% | +$96.8K | ﹤0.01% | 3629 |
|
|
2023
Q3 | $444K | Buy |
81,468
+24,489
| +43% | +$133K | ﹤0.01% | 3555 |
|
|
2023
Q2 | $382K | Buy |
56,979
+5,254
| +10% | +$35.3K | ﹤0.01% | 3631 |
|
|
2023
Q1 | $457K | Buy |
51,725
+3,500
| +7% | +$30.9K | ﹤0.01% | 3393 |
|
|
2022
Q4 | $368K | Buy |
48,225
+4,390
| +10% | +$33.5K | ﹤0.01% | 3493 |
|
|
2022
Q3 | $312K | Sell |
43,835
-292
| -0.7% | -$2.08K | ﹤0.01% | 3526 |
|
|
2022
Q2 | $357K | Sell |
44,127
-33,008
| -43% | -$267K | ﹤0.01% | 3458 |
|
|
2022
Q1 | $1.07M | Buy |
77,135
+35,454
| +85% | +$492K | ﹤0.01% | 2551 |
|
|
2021
Q4 | $1.17M | Buy |
41,681
+2,940
| +8% | +$82.5K | ﹤0.01% | 2515 |
|
|
2021
Q3 | $1.32M | Buy |
38,741
+1,706
| +5% | +$58K | ﹤0.01% | 2384 |
|
|
2021
Q2 | $1.51M | Buy |
37,035
+16,616
| +81% | +$679K | ﹤0.01% | 2197 |
|
|
2021
Q1 | $822K | Buy |
20,419
+15,717
| +334% | +$633K | ﹤0.01% | 2566 |
|
|
2020
Q4 | $278K | Buy |
+4,702
| New | +$278K | ﹤0.01% | 3250 |
|
|
2020
Q3 | – | Sell |
-19,352
| Closed | -$936K | – | 3527 |
|
|
2020
Q2 | $936K | Buy |
+19,352
| New | +$936K | ﹤0.01% | 1860 |
|
|
2020
Q1 | – | Sell |
-26,603
| Closed | -$796K | – | 3196 |
|
|
2019
Q4 | $796K | Buy |
+26,603
| New | +$796K | ﹤0.01% | 2005 |
|